Aspira Women's Health Inc. SEC filings AWHL
Aspira Women's Health Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 12, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (material agreement, new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jan 12, 2026 | — |
| S-1 | Registration statement | Dec 31, 2025 | — |
| 424B3 | Prospectus | Nov 21, 2025 | — |
| S-1/A | Amended registration statement | Oct 20, 2025 | — |
| S-1 | Registration statement | Sep 30, 2025 | — |
| S-8 | Employee stock plan registration | Jun 9, 2025 | — |
| 424B3 | Prospectus | May 7, 2025 | — |
| S-1/A | Amended registration statement | May 6, 2025 | — |
| S-1/A | Amended registration statement | May 1, 2025 | — |
| S-1 | Registration statement | Apr 16, 2025 | — |
| S-1/A | Amended registration statement | Feb 11, 2025 | — |
| FWP | Free writing prospectus | Jan 31, 2025 | — |
| S-1/A | Amended registration statement | Jan 31, 2025 | — |
| S-1 | Registration statement | Jan 8, 2025 | — |
| 424B3 | Prospectus | Sep 5, 2024 | — |
| S-3 | Shelf registration | Aug 23, 2024 | — |
| S-8 | Employee stock plan registration | Aug 20, 2024 | — |
| 424B5 | Prospectus supplement | Aug 2, 2024 | — |
| 424B3 | Prospectus | Jul 25, 2024 | — |
| S-3 | Shelf registration | Jul 17, 2024 | — |
| 424B5 | Prospectus supplement | Apr 26, 2024 | — |
| S-3 | Shelf registration | Apr 22, 2024 | — |
| 424B3 | Prospectus | Apr 11, 2024 | — |
| S-1 | Registration statement | Apr 5, 2024 | — |
| S-8 | Employee stock plan registration | Jan 26, 2024 | — |
| 424B5 | Prospectus supplement | Jan 26, 2024 | — |
| 424B5 | Prospectus supplement | Jul 24, 2023 | — |
| 424B5 | Prospectus supplement | Mar 29, 2023 | — |
| 424B5 | Prospectus supplement | Feb 10, 2023 | — |
| 424B5 | Prospectus supplement | Aug 24, 2022 | — |
| 424B5 | Prospectus supplement | Aug 22, 2022 | — |
| 424B5 | Prospectus supplement | Feb 5, 2021 | — |
| 424B5 | Prospectus supplement | Feb 3, 2021 | — |
| S-3 | Shelf registration | Jan 20, 2021 | — |
| 424B3 | Prospectus | Oct 1, 2020 | — |
| S-3 | Shelf registration | Sep 18, 2020 | — |
| S-8 | Employee stock plan registration | Jul 3, 2019 | — |
| 424B5 | Prospectus supplement | Jun 27, 2019 | — |
| 424B5 | Prospectus supplement | Jun 25, 2019 | — |
| S-8 | Employee stock plan registration | Jul 31, 2018 | — |
| 424B5 | Prospectus supplement | Apr 17, 2018 | — |
| 424B5 | Prospectus supplement | Apr 16, 2018 | — |
| 424B5 | Prospectus supplement | Apr 12, 2018 | — |
| 424B5 | Prospectus supplement | Apr 12, 2018 | — |
| S-3 | Shelf registration | Oct 24, 2017 | — |
| 424B3 | Prospectus | May 8, 2017 | — |
| S-3 | Shelf registration | Apr 11, 2017 | — |
| S-8 | Employee stock plan registration | Jul 24, 2015 | — |
| 424B5 | Prospectus supplement | Jul 14, 2015 | — |
| 424B5 | Prospectus supplement | Jul 13, 2015 | — |
| 424B3 | Prospectus | May 13, 2015 | — |
| S-3/A | Filing | May 8, 2015 | — |
| S-3 | Shelf registration | Feb 11, 2015 | — |
| S-3/A | Filing | Oct 1, 2014 | — |
| S-3 | Shelf registration | Sep 15, 2014 | — |
| S-8 | Employee stock plan registration | Jan 10, 2014 | — |
| S-3 | Shelf registration | Jul 12, 2013 | — |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- AWHL (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 926617
- Former names
- VERMILLION, INC. (until Jun 10, 2020); CIPHERGEN BIOSYSTEMS INC (until Aug 17, 2007)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.